ArticleMycology2022
A case of
Article in Mycology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.
- Antifungal resistance and poor clinical outcome rates ofFrontiers in microbiology · 2026Pooled it
- Review
- Candida auris vacuolar calcium pump mediates fluconazole efflux and resistance evolution.Nature microbiology · 2026Article
- Development of New Drug Against Multidrug-ResistantPharmaceutics · 2026Article
- Molecular epidemiological characteristics, antifungal resistance and pathogenicity of Candidozyma auris in Guangzhou, South China.BMC microbiology · 2025Article
- Article
- Article
- Impact of pH, Temperature and Exogenous Proteins on Aspartic Peptidase Secretion inPathogens (Basel, Switzerland) · 2025Article
- Signaling pathways governing the pathobiological features and antifungal drug resistance ofmBio · 2025Review
- Two outbreaks and sporadic occurrences of Candida auris from one hospital in China: an epidemiological, genomic retrospective study.Infection · 2025Article
- The multidrug-resistantCurrent research in microbial sciences · 2025Review
- First report ofEmerging microbes & infections · 2024Article
- Comprehensive Overview ofJournal of microbiology and biotechnology · 2024Review
- Review
- The role of fungi in the diagnosis of colorectal cancer.Mycology · 2024Review
- Review
- Clinical isolates of Candida auris with enhanced adherence and biofilm formation due to genomic amplification of ALS4.PLoS pathogens · 2023Article
- Risk factors and mortality of the newly emergingMycology · 2023Article
- A Candidemia Case Caused by a Novel Drug-ResistantInfection and drug resistance · 2023Article
- Burden of fungal infections in Kenya.Mycology · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 3 institutions in 2 countries.
Funding
Abstract
The recently emerged fungal pathogen
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.